Sharon Hanegraaf
Vice President of Regulatory Affairs / Argenica Therapeutics
| Rank | Company | # | |
|---|---|---|---|
| 110th | - | Argenica Therapeutics | $3.21m |
| 119th | - | Sprintex | $1.94m |
| 120th | - | icetana AI | $1.90m |
| 121st | - | CAQ Holdings | $1.89m |
| 122nd | - | EVE Health Group | $1.74m |
| Rank | Company | 1 Yr | 5 Yr |
|---|---|---|---|
| 1624th | Cann Group | -71.9% | -57.7% |
| 1625th | Step One Clothing | -71.96% | 0% |
| 1626th | Argenica Therapeutics | -72.15% | 0% |
| 1627th | OncoSil Medical | -72.64% | -53.51% |
| 1628th | Melbana Energy | -73.36% | -18.82% |
|
NEWS: Tagged in Board moves August 7, 2025 | 07 Aug 2025 |
|
NEW ROLE: Vice President of Regulatory Affairs, Argenica Therapeutics | 07 Aug 2025 |
Access to our data for Sharon Hanegraaf is only available to paid subscribers with Data & Insights access.
Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.
Sharon Hanegraaf is linked to 1 organisation which is included in 1 list - Public Companies - Industrial WA.
To see the data you will need to Subscribe.